Jan 26, 2026 08:15AM
Jan 20, 2026 08:45AM
Dec 18, 2025 08:15AM
Dec 5, 2025 04:55PM
Aug 26, 2025 09:38AM
Aug 20, 2025 08:01AM
Aug 20, 2025 08:00AM Tharimmune Reports Pharmacokinetic Simulation Results for TH104 as Prophylaxis Against Respiratory Depression from Fentanyl and Ultrapotent Opioids, Highlighting Potential Superiority Over Existing Tr
Aug 13, 2025 08:01AM
Aug 13, 2025 08:01AM
Aug 5, 2025 08:00AM
Aug 5, 2025 08:00AM
Aug 4, 2025 08:01AM
Aug 4, 2025 08:00AM
Jun 17, 2025 08:13AM Tharimmune (THAR) Announces Key Leadership Appointments
Jun 17, 2025 08:01AM
May 19, 2025 08:01AM
May 6, 2025 08:03AM
May 6, 2025 08:01AM
May 1, 2025 08:01AM
Apr 30, 2025 08:03AM
Apr 30, 2025 08:01AM Tharimmune Appoints Clay Kahler and Gary Stetz to its Board of Directors
Apr 28, 2025 08:04AM
Apr 28, 2025 08:01AM
Apr 15, 2025 09:00AM
Apr 7, 2025 08:00AM
Mar 31, 2025 08:03AM
Mar 31, 2025 08:00AM
Mar 24, 2025 08:00AM Tharimmune Announces Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-alpha
Mar 4, 2025 07:03AM
Mar 4, 2025 07:00AM
Jan 27, 2025 08:30AM
Dec 19, 2024 04:18PM
Dec 16, 2024 08:04AM
Dec 16, 2024 08:00AM
Dec 6, 2024 04:20PM Tharimmune (THAR) Announces 961K Share Offering at $2.10/sh
Dec 6, 2024 04:15PM
Dec 6, 2024 09:57AM
Nov 27, 2024 07:00AM
Nov 27, 2024 07:00AM
Nov 18, 2024 08:00AM
Nov 13, 2024 08:03AM
Nov 13, 2024 08:00AM Tharimmune Granted European Patent for Delivery of Optimized Molecularly Targeted Therapeutics
Nov 4, 2024 09:00AM
Oct 30, 2024 08:16AM
Oct 30, 2024 08:00AM
Oct 28, 2024 09:12AM
Oct 28, 2024 09:00AM
Oct 25, 2024 08:00AM
Sep 30, 2024 07:23AM Tharimmune (THAR) to Merge With Intract Pharma
Sep 30, 2024 07:00AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All